Comparison of FDG PET/CT and Gadolinium-Enhanced MRI for the Detection of Bone Metastases in Patients With Cancer

Even-Sapir, 2005, Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities., J Nucl Med, 46, 1356

Blake, 2001, Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate., Semin Nucl Med, 31, 28, 10.1053/snuc.2001.18742

Tryciecky, 1997, Oncologic imaging: interactions of nuclear medicine with CT and MRI using the bone scan as a model., Semin Nucl Med, 27, 142, 10.1016/S0001-2998(97)80044-X

Cook, 1998, Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions., J Clin Oncol, 16, 3375, 10.1200/JCO.1998.16.10.3375

Chung, 2003, Comparison with 99mTc MDP bone scintigraphy and whole body 18FDG PET for the evaluation of bone metastases in patients with lung cancer., Tuberc Respir Dis, 55, 280, 10.4046/trd.2003.55.3.280

Ohno, 2008, Non-small cell lung cancer: whole-body MR examination for M-stage assessmentutility for whole-body diffusion-weighted imaging compared with integrated FDG PETCT., Radiology, 248, 643, 10.1148/radiol.2482072039

Ng, 2009, Pretreatment evaluation of distant-site status with nasopharyngeal carcinoma: accuracy of whole-body MRI at 3-tesla and FDG-PET-CT., Eur Radiol, 19, 1366, 10.1007/s00330-009-1504-5

Schmidt, 2005, High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system., Invest Radiol, 40, 743, 10.1097/01.rli.0000185878.61270.b0

Antoch, 2003, Whole-body dual-modality PETCT and whole-body MRI for tumor staging in oncology., JAMA, 290, 3199, 10.1001/jama.290.24.3199

Walker, 2001, Whole-body magnetic resonance imaging: techniques, clinical indications, and future applications., Semin Musculoskelet Radiol, 5, 5, 10.1055/s-2001-12923

Whiting, 2003, The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews., BMC Med Res Methodol, 3, 25, 10.1186/1471-2288-3-25

Chu, 2006, Bivariate meta-analysis of sensitivity and specificity with sparse data: a general linear mixed model approach., J Clin Epidemiol, 59, 1331, 10.1016/j.jclinepi.2006.06.011

Jaeschke, 1994, Users guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients The Evidence-Based Medicine Working Group., JAMA, 271, 703, 10.1001/jama.1994.03510330081039

Heusner, 2010, Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PETCT for whole-body breast cancer staging., Eur J Nucl Med Mol Imaging, 37, 1077, 10.1007/s00259-010-1399-z

Takenaka, 2009, Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PETCT, and bone scintigraphy., J Magn Reson Imaging, 30, 298, 10.1002/jmri.21858

Kumar, 2008, Whole-body MR imaging with the use of parallel imaging for detection of skeletal metastases in pediatric patients with small-cell neoplasms: comparison with skeletal scintigraphy and FDG PETCT., Pediatr Radiol, 38, 953, 10.1007/s00247-008-0921-y

Grankvist, 2012, MRI and PETCT of patients with bone metastases from breast carcinoma., Eur J Radiol, 81, e13, 10.1016/j.ejrad.2010.10.024

Pfannenberg, 2007, Prospective comparison of 18F-fluorodeoxyglucose positron emission tomographycomputed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma., Eur J Cancer, 43, 557, 10.1016/j.ejca.2006.11.014

Laurent, 2010, Comparative study of two whole-body imaging techniques in the case of melanoma metastases: advantages of multi-contrast MRI examination including a diffusion-weighted sequence in comparison with PET-CT., Eur J Radiol, 75, 376, 10.1016/j.ejrad.2009.04.059

Yi, 2008, Non-small cell lung cancer staging: efficacy comparison of integrated PETCT versus 3.0-T whole-body MR imaging., Radiology, 248, 632, 10.1148/radiol.2482071822

Heusner, 2011, One-stop-shop staging: should we prefer FDG-PETCT or MRI for the detection of bone metastases Eur J Radiol., , 78, 430

Ng, 2010, Comprehensive imaging of residualrecurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT., Eur Radiol, 20, 2229, 10.1007/s00330-010-1784-9

Chan, 2011, 18F-FDG PETCT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngealhypopharyngeal carcinoma: a comparative study., Eur J Nucl Med Mo Imaging, 38, 1607, 10.1007/s00259-011-1824-y

Ng, 2011, PETCT and 3T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma., Eur J Nucl Med Mol Imaging, 38, 996, 10.1007/s00259-011-1740-1

Schirrmeister, 1999, Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography., J Clin Oncol, 17, 2381, 10.1200/JCO.1999.17.8.2381

Cook, 1999, Skeletal metastases from breast cancer: imaging with nuclear medicine., Semin Nucl Med, 29, 69, 10.1016/S0001-2998(99)80031-2

Yang, 2011, Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy., Eur Radiol, 21, 2604, 10.1007/s00330-011-2221-4

Antoch, 2005, Whole-Body dual-modality fluorine-18-2-fluo-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET-CT) for tumor staging in solid tumor: comparison with CT and PET., J Clin Oncol, 22, 4357, 10.1200/JCO.2004.08.120

Glas, 2003, The diagnostic odds ratio: a single indicator of test performance., J Clin Epidemiol, 56, 1129, 10.1016/S0895-4356(03)00177-X

Gourlay, 2008, Clinical performance of osteoporosis risk assessment tools in women aged 67 years and older., Osteoporos Int, 19, 1175, 10.1007/s00198-007-0555-1